Health, Wellness & Fitness - Zibo, Shandong, China
Hantide Biomedical Group Co, Ltd., founded in June, 2019, registered capital ¥75,000,000, share controlled by a listed company named Dezhan Healthcare, is a high-tech Enterprise focusing on the development of synthetic biology and majoring mainly on the designing, producing and selling of novel gene-recombining Polypeptide Drugs. Our company owns the advanced R&D group formed by the overseas returnees and domestic leading figures and developing substantial technology cooperation with overseas and domestic colleges. And our R&D Centers are located in Shandong,Tianjin and Jiangsu, covering area of more than 6000 sqm, equipped with labs for gene-edition, for enzyme projects, for polypeptide high-throughput synthesis and for quality management and control. Based on the design and synthesis of active polypeptide combined with the advanced synthetic biology technology, the development and production of gene-recombining polypeptide and novel antibody drugs is realized.Our company now is staffed by more than 140 employees, including more than 40 technicians or R & D persons. And our company is structured by 2 research institutes, 3 centers and 3 production bases. Two Research Institutes consist of Shandong University - Hantide Biotechnology Research Institute, finished, and Hantide Biomedical - Jiangsu Research Institute, under construction. Three Centers are composed by Operations Management Center, Marketing Center and Comprehensive Management Center.Three Production Bases refer to Medical Beauty Project Production Base (Hantide Medical Beauty Biotech Co., Ltd.) in Huantai County of Shandong, Project Production Base in Gaoqing County of Shandong and Project Production Base in Donghai County of Jiangsu (Jiangsu Hantai Biomedical Co., Ltd.)
ASP.NET
Microsoft-IIS
Bootstrap Framework